New partnership - Recipharm

Epi-Endo Pharmaceuticals are proud to announce our new partnership with Recipharm, a Swedish Contract Development and Manufacturing Organisation (CDMO). Epi-Endo and Recipharm will be collaborating in the synthesis of our novel compound, which will be led by Fredrik Lehman, our CMC Director and General Manager at Recipharm .

Recipharm was founded in 1995 and is one of the leading CDMOs in the industry. The company is listed on the Swedish stock exchange.